Clinical trial
Compassionate Use of Stanate (TM) [Stannsoporfin]
NCT00076960 · InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company, Industry · No longer available
Key facts
| NCT number | NCT00076960 |
|---|---|
| Title | Compassionate Use of Stanate (TM) [Stannsoporfin] |
| Official title | Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions |
| Lead sponsor | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Neonatal Jaundice, Hyperbilirubinemia |
| Intervention type | Drug |
| Interventions | Stanate (TM) [stannsoporfin, tin-mesoporphyrin] |
| First posted | Feb 10, 2004 |
| Last update posted | Oct 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: